The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Maxwell John T. since 2018.
The trader's CIK number is 1739025.
At the time of the last reporting, Maxwell John T. was the SVP-Chief Financial Officer of Aquestive Therapeutics, Inc.. (stock ticker symbol AQST).
Also see all insider trading activities at Aquestive Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | AQST | 0 | $0 | 3,000 | $24,000 | 0 | $0 |
| 2018 | AQST | 15,000 | $142,349 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-08-18 | AQST | Sale | 3,000 | 8.00 | 24,000 |
| 2018-12-06 | AQST | Buy | 5,000 | 8.87 | 44,349 |
| 2018-11-21 | AQST | Buy | 10,000 | 9.80 | 98,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Maxwell John T. (SVP-Chief Financial Officer of Aquestive Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.